Skip to content

Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated

Near-global nelfinavir (Viracept) recall 'very difficult situation'

Nelfinavir (Viracept) recall update

Nelfinavir (Viracept) recalled in UK and Europe following contamination alert

Is there any clinical benefit to staying on a failing regimen?

Further development of resistance infrequent in patients taking tenofovir despite low-level viremia and K65R mutation

CROI: MSF reports good responses on PI-based second-line ART regimens even though switch from failing regimens comes late

Previous poor adherence and HCV are risk factors for antiretroviral treatment failure

Is genetic screening for abacavir hypersensitivity risk appropriate for black Africans?